has decreased by 6.30% despite total hospital income from general patients increased 8.69% compared with the same period of last year. This is mainly due to the medical-service-fee adjustment caused by
terminal growth rate and discounted rate used in the assumptions are based on management of the subsidiary’s judgment and past experience and business plan, as well as the future prediction that is believed
assumptions are based on management of the subsidiary’s judgment and past experience and business plan, as well as the future prediction that is believed to be reasonable in the present situation and compared
, as well as the future prediction that is believed to be reasonable in the present situation and compared to the carrying amount of assets related to the licenses. Conclusion : The Group reported a loss
not always tally with consolidated financials due to holding segment 3Excludes price adjustment for captive sales on freight saving. This does not have any impact on regional or consolidated EBITDA
. Segments total may not match to IVL due to holdings segment. Excluding Feedstock price adjustment for captive sales to PET on freight saving. There are no impacts on regional or consolidated EBITDA. Summary
Board 2/2018 on February 22, 2018 has been approved the financial statements for year ended 31 December 2017. The basis for Qualified Opinion cause the effects of adjustment, if any, did not observe the
the future prediction that is believed to be reasonable in the present situation and compared to the carrying amount of assets related to the licenses. In addition, the Group has adjusted and restated
in blue. No. ORI 94/2018 10 November 2018 Subject: Resolution of the Board of Directors' Meeting No. 12/2561 Adjustment of the Exercise Ratio by adjusting Number of ORI-W1 and approval of the asset